98 related articles for article (PubMed ID: 31495292)
1. Metformin's effectiveness in preventing prednisone-induced hyperglycemia in hematological cancers.
Ochola LA; Nyamu DG; Guantai EM; Weru IW
J Oncol Pharm Pract; 2020 Jun; 26(4):823-834. PubMed ID: 31495292
[TBL] [Abstract][Full Text] [Related]
2. Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials.
DeFronzo RA; Buse JB; Kim T; Burns C; Skare S; Baron A; Fineman M
Diabetologia; 2016 Aug; 59(8):1645-54. PubMed ID: 27216492
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic metformin after antenatal corticosteroids (PROMAC): a double blind randomized controlled trial.
Hong JGS; Tan PC; Kamarudin M; Omar SZ
BMC Pregnancy Childbirth; 2021 Feb; 21(1):138. PubMed ID: 33588801
[TBL] [Abstract][Full Text] [Related]
4. Effects of postmeal exercise on postprandial glucose excursions in people with type 2 diabetes treated with add-on hypoglycemic agents.
Erickson ML; Little JP; Gay JL; McCully KK; Jenkins NT
Diabetes Res Clin Pract; 2017 Apr; 126():240-247. PubMed ID: 28284168
[TBL] [Abstract][Full Text] [Related]
5. Effects of 6-month eicosapentaenoic acid treatment on postprandial hyperglycemia, hyperlipidemia, insulin secretion ability, and concomitant endothelial dysfunction among newly-diagnosed impaired glucose metabolism patients with coronary artery disease. An open label, single blinded, prospective randomized controlled trial.
Sawada T; Tsubata H; Hashimoto N; Takabe M; Miyata T; Aoki K; Yamashita S; Oishi S; Osue T; Yokoi K; Tsukishiro Y; Onishi T; Shimane A; Taniguchi Y; Yasaka Y; Ohara T; Kawai H; Yokoyama M
Cardiovasc Diabetol; 2016 Aug; 15(1):121. PubMed ID: 27565734
[TBL] [Abstract][Full Text] [Related]
6. Effect of exenatide on 24-hour blood glucose profile compared with placebo in patients with type 2 diabetes: a randomized, double-blind, two-arm, parallel-group, placebo-controlled, 2-week study.
Schwartz SL; Ratner RE; Kim DD; Qu Y; Fechner LL; Lenox SM; Holcombe JH
Clin Ther; 2008 May; 30(5):858-67. PubMed ID: 18555933
[TBL] [Abstract][Full Text] [Related]
7. Modification of postprandial hyperglycemia with insulin lispro improves glucose control in patients with type 2 diabetes.
Feinglos MN; Thacker CH; English J; Bethel MA; Lane JD
Diabetes Care; 1997 Oct; 20(10):1539-42. PubMed ID: 9314631
[TBL] [Abstract][Full Text] [Related]
8. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effect of xylose consumption on postprandial hyperglycemia in Korean: a randomized double-blind, crossover design.
Jun YJ; Lee J; Hwang S; Kwak JH; Ahn HY; Bak YK; Koh J; Lee JH
Trials; 2016 Mar; 17(1):139. PubMed ID: 26979433
[TBL] [Abstract][Full Text] [Related]
10. Humalog Mix 25 in patients with type 2 diabetes which do not achieve acceptable glycemic control with oral agents: results from a phase III, randomized, parallel study.
Tîrgovişte CI; Străchinariu R; Farcaşiu E; Milicevic Z; Teodorescu G
Rom J Intern Med; 2003; 41(2):153-62. PubMed ID: 15526500
[TBL] [Abstract][Full Text] [Related]
11. Postmeal exercise blunts postprandial glucose excursions in people on metformin monotherapy.
Erickson ML; Little JP; Gay JL; McCully KK; Jenkins NT
J Appl Physiol (1985); 2017 Aug; 123(2):444-450. PubMed ID: 28522762
[TBL] [Abstract][Full Text] [Related]
12. Metformin prevents metabolic side effects during systemic glucocorticoid treatment.
Seelig E; Meyer S; Timper K; Nigro N; Bally M; Pernicova I; Schuetz P; Müller B; Korbonits M; Christ-Crain M
Eur J Endocrinol; 2017 Mar; 176(3):349-358. PubMed ID: 28073907
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of glimepiride/metformin combination versus glibenclamide/metformin in patients with uncontrolled type 2 diabetes mellitus.
González-Ortiz M; Guerrero-Romero JF; Violante-Ortiz R; Wacher-Rodarte N; Martínez-Abundis E; Aguilar-Salinas C; Islas-Andrade S; Arechavaleta-Granell R; González-Canudas J; Rodríguez-Morán M; Zavala-Suárez E; Ramos-Zavala MG; Metha R; Revilla-Monsalve C; Beltrán-Jaramillo TJ
J Diabetes Complications; 2009; 23(6):376-9. PubMed ID: 18849173
[TBL] [Abstract][Full Text] [Related]
14. Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.
Carroll MF; Izard A; Riboni K; Burge MR; Schade DS
Diabetes Care; 2002 Dec; 25(12):2147-52. PubMed ID: 12453952
[TBL] [Abstract][Full Text] [Related]
15. The effect of metformin on glucose metabolism in patients receiving glucocorticoids.
Landis D; Sutter A; Fernandez F; Nugent K
Am J Med Sci; 2022 Oct; 364(4):379-385. PubMed ID: 35525318
[TBL] [Abstract][Full Text] [Related]
16. Control of Postprandial Hyperglycemia in Type 1 Diabetes by 24-Hour Fixed-Dose Coadministration of Pramlintide and Regular Human Insulin: A Randomized, Two-Way Crossover Study.
Riddle MC; Nahra R; Han J; Castle J; Hanavan K; Hompesch M; Huffman D; Strange P; Öhman P
Diabetes Care; 2018 Nov; 41(11):2346-2352. PubMed ID: 30213882
[TBL] [Abstract][Full Text] [Related]
17. Continuous glucose profiles with vildagliptin versus sitagliptin in add-on to metformin: results from the randomized Optima study.
Guerci B; Monnier L; Serusclat P; Petit C; Valensi P; Huet D; Raccah D; Colette C; Quéré S; Dejager S
Diabetes Metab; 2012 Oct; 38(4):359-66. PubMed ID: 22809630
[TBL] [Abstract][Full Text] [Related]
18. Postprandial hyperglycemia was ameliorated by taking metformin 30 min before a meal than taking metformin with a meal; a randomized, open-label, crossover pilot study.
Hashimoto Y; Tanaka M; Okada H; Mistuhashi K; Kimura T; Kitagawa N; Fukuda T; Majima S; Fukuda Y; Tanaka Y; Yamada S; Senmaru T; Hamaguchi M; Asano M; Yamazaki M; Oda Y; Hasegawa G; Nakamura N; Fukui M
Endocrine; 2016 May; 52(2):271-6. PubMed ID: 26518190
[TBL] [Abstract][Full Text] [Related]
19. The role of adding metformin in insulin-resistant diabetic pregnant women: a randomized controlled trial.
Ibrahim MI; Hamdy A; Shafik A; Taha S; Anwar M; Faris M
Arch Gynecol Obstet; 2014 May; 289(5):959-65. PubMed ID: 24217938
[TBL] [Abstract][Full Text] [Related]
20. [The effect of metformin on fasting and postprandial insulin secretion in obese patients with diabetes mellitus type 2].
Vuković M; Lapcević M; Kalezić N; Gvozdenović BS
Srp Arh Celok Lek; 2007; 135(7-8):447-52. PubMed ID: 17929538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
